Spinal muscular atrophy: new findings for an old pathology

Daniele Bottai1, Raffaella Adami

  • 1Department of Science Health, University of Milan, Milano, Italy.

Insights

Spinal muscular atrophy (SMA), a rare neurodegenerative disease, impacts young individuals and their families. Understanding the sequence of neuronal degeneration is key to developing effective therapeutic strategies for SMA.

Area of Science:

  • Neuroscience
  • Genetics
  • Pathology

Background:

  • Spinal muscular atrophy (SMA) is a rare, devastating neurodegenerative disease affecting young people.
  • It imposes significant emotional and financial burdens on families, requiring intensive care.
  • SMA is primarily linked to loss-of-function mutations in the SMN1 gene, affecting lower motor neurons.

Purpose of the Study:

  • To investigate the sequence of neuronal degeneration events in SMA.
  • To explore potential alterations beyond lower motor neuron pathology, including muscle-motor neuron crosstalk.
  • To examine the role of physical inactivity in SMA progression.

Main Methods:

  • Review of existing literature on SMA pathology and neuronal degeneration.
  • Analysis of molecular defects and their impact on neuronal compartments (cell body, axon, synapse).
  • Exploration of inter-organ communication pathways and lifestyle factors.

Main Results:

  • Neuronal degeneration in SMA is asynchronous, with varying vulnerabilities among neuron subpopulations.
  • The sequence of degeneration (synapse, axon, or cell body) provides insights into underlying molecular defects.
  • SMA may involve complex interactions between muscle and motor neurons, influenced by physical activity levels.

Conclusions:

  • Understanding the precise sequence of neuronal degeneration is crucial for SMA therapeutic strategies.
  • Beyond the primary genetic defect, SMA pathology involves intricate cellular and systemic interactions.
  • Further research into muscle-motor neuron crosstalk and the impact of inactivity is warranted for comprehensive SMA management.

Related Concept Videos

Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Alterations in Muscle Tone ll01:12

Alterations in Muscle Tone ll

Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
Secondary Spinal Cord Injury llI: Pathophysiology01:25

Secondary Spinal Cord Injury llI: Pathophysiology

Early Ischemia and Ionic ImbalanceWithin minutes of spinal cord injury, a secondary cascade begins, progressing over hours to weeks. Vascular damage reduces blood flow, causing ischemia and mitochondrial dysfunction. ATP depletion leads to ion pump failure, membrane depolarization, sodium influx, potassium efflux, and water accumulation, resulting in cellular swelling. Increased intracellular calcium further disrupts mitochondria and accelerates cellular injury.Excitotoxicity and Neuronal...